Are these 3 beaten down ASX shares in the bargain bin?

The Domino's Pizza Enterprises Ltd. (ASX:DMP) share price is one of three down significantly in the last 12 months. Is it time to invest?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite a spot of weakness during the last couple of months, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has managed to carve out a reasonably solid gain of 5% since this time last year.

Unfortunately not all shares on the market have been able to follow the index higher. In fact, a few have been absolutely crushed during this time.

Three in particular which caught my eye are listed below. Are they in the bargain bin now?

The Domino's Pizza Enterprises Ltd. (ASX: DMP) share price has fallen 41% since this time last year. Concerns over allegations of staff underpayment by franchisees and a full-year earnings miss are largely behind the severe decline. This means that the pizza chain operator's shares are now changing hands at just 29x earnings. Whilst this is still a premium to the market-average, I think this is cheap for a company with such strong long-term growth prospects. I remain optimistic that FY 2017 was just a blip and that the company will return to form in FY 2018.

The Mayne Pharma Group Ltd (ASX: MYX) share price has plunged a whopping 66% in the last 12 months as a result of competitive pricing pressures in the U.S. generic drugs market. While management is looking to offset this by accelerating the growth of its Specialty Brands segment and cutting costs, at this stage it is unclear whether these moves will be enough. Mayne Pharma could end up being an absolute bargain at the current share price, but I'm keeping my powder dry until at least its half-year results.

The Resapp Health Ltd (ASX: RAP) share price has lost 78% of its value since this time last year. The majority of this decline came in the last few weeks after the company released negative results relating to its Smartcough C study. However, earlier this week management advised that due to a number of issues during execution and adjudication, the study was not a representative evaluation of its ResAppDx app. As a result, the study will restart in the U.S winter. I would suggest investors wait for the results of the next study before parting with any hard-earned money.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »